United States was AVITA Medical’s largest region in fiscal 2025, bringing in $68.79M of $71.61M (96%).
| Geography | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $33.26M | $46.36M | $62.16M | $68.79M | |||||
| Japan | $729.00K | $3.37M | $1.43M | $2.09M | |||||
| Australia | $275.00K | $222.00K | $312.00K | $200.00K | |||||
| United Kingdom | $160.00K | $141.00K | $196.00K | $486.00K | |||||
| European Union | — | $51.00K | $155.00K | $49.00K | |||||
| Total | $34.42M | $50.14M | $64.25M | $71.61M |
AVITA Medical brought in $71.61M from its five regions in fiscal 2025, the year ended December 31, 2025. That was up 11.5% from $64.25M in fiscal 2024. United States was the largest at $68.79M (96.1%), ahead of Japan at $2.09M (2.9%) and United Kingdom at $486.00K (0.7%). The other two regions brought in $249.00K combined.
Compared with fiscal 2024, Japan grew 45.9% to $2.09M and United States grew 10.7% to $68.79M.
AVITA Medical began breaking out European Union in fiscal 2023, when it brought in $51.00K.
Commercial Sales was AVITA Medical’s largest revenue line in fiscal 2025, bringing in $71.44M of $71.61M (100%).
| Customer | FY 2019 | FY 2020 | FY 2021 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| Commercial Sales | $34.05M | $49.78M | $64.02M | $71.44M | ||||
| Product Sales | — | — | — | — | ||||
| Services For Emergency Preparedness | $370.00K | — | — | — | ||||
| Barda Revenue For Right Of First Access | — | $335.00K | $195.00K | $139.00K | ||||
| Deferred Commercial Revenue Recognized | — | $33.00K | $33.00K | $33.00K | ||||
| Total | $34.42M | $50.14M | $64.25M | $71.61M |
AVITA Medical brought in $71.61M from its three revenue lines in fiscal 2025, the year ended December 31, 2025. That was up 11.5% from $64.25M in fiscal 2024. Commercial Sales was the largest at $71.44M (99.8%), ahead of Barda Revenue For Right Of First Access at $139.00K (0.2%) and Deferred Commercial Revenue Recognized at $33.00K (0.0%).
AVITA Medical began breaking out Barda Revenue For Right Of First Access in fiscal 2023 and Deferred Commercial Revenue Recognized in fiscal 2023. AVITA Medical stopped reporting Services For Emergency Preparedness as a separate revenue line after fiscal 2022, when it brought in $370.00K.
Recell System was AVITA Medical’s largest product and service line in fiscal 2025, bringing in $66.46M of $71.44M (93%).
| Product and Service | FY 2024 | FY 2025 |
|---|---|---|
| Recell System | $62.61M | $66.46M |
| Other Wound Care Products | $1.05M | $4.25M |
| Lease Revenue | $358.00K | $731.00K |
| Total | $64.02M | $71.44M |
AVITA Medical brought in $71.44M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 11.6% from $64.02M in fiscal 2024. Recell System was the largest at $66.46M (93.0%), ahead of Other Wound Care Products at $4.25M (5.9%) and Lease Revenue at $731.00K (1.0%).
Compared with fiscal 2024, Other Wound Care Products grew 302.8% to $4.25M and Recell System grew 6.1% to $66.46M.
AVITA Medical (RCEL) reports its revenue by geography, by customer and by product and service. In fiscal 2025, United States was its largest region, bringing in $68.79M (96.1% of the total), followed by Japan at $2.09M (2.9%).
United States was AVITA Medical's largest region in fiscal 2025, bringing in $68.79M, or 96.1% of the $71.61M total across its five regions.
Commercial Sales was AVITA Medical's largest revenue line in fiscal 2025, bringing in $71.44M, or 99.8% of the $71.61M total across its three revenue lines.
Recell System was AVITA Medical's largest product and service line in fiscal 2025, bringing in $66.46M, or 93.0% of the $71.44M total across its three product and service lines.
Japan grew faster than United States in fiscal 2025, up 45.9% from $1.43M to $2.09M. United States grew 10.7% to $68.79M.
Every figure comes from AVITA Medical's annual financial filings, as reported. Each line keeps the name AVITA Medical gives it, and years follow its fiscal calendar.
AVITA Medical's revenue by geography goes back to fiscal 2018, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.